Clinical Trial

Impact of Podcast-Based Breastfeeding Education During Pregnancy on Breastfeeding Self-Efficacy in Pregnant Women

Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated February 25, 2025 (before its estimated March 21, 2025 completion). Its status may not reflect the trial's current state.
Summary
Women who meet the sampling selection criteria will be introduced and informed about the study. Considering the patients who meet the research criteria and accept the study, patients will be divided into groups according to whether their barcode numbers are odd or even (1:1 ratio), provided that the number of individuals in the intervention and control groups is equal. It is planned to work with a total of 80 pregnant women, considering the losses. The intervention and control groups will be selected by drawing lots. The Introductory Information Form and Prenatal Breastfeeding Self-Efficacy Scale will be filled out by the women who meet the sampling selection criteria and accept to participate in the study before the application. The content of the podcast-based education to be given to the pregnant women in the intervention group will be created by the researcher and the consultant, and expert opinion will be obtained regarding the content. For the pregnant women in the control group; a brochure will be prepared for breastfeeding education and expert opinion will be obtained. The brochure prepared by the researcher and the consultant will be given to the pregnant women in the control group at the planned time. The pregnant women in the intervention group will be given a period of two weeks to complete the prepared podcast education. At the end of the two-week period, pregnant women in the intervention and control groups will be asked to fill out the Prenatal Breastfeeding Self-Efficacy Scale again.
Trial Details
NCT Number NCT06844929
Lead Sponsor Suleyman Demirel University
Conditions Pregnant Women, Breastfeeding
Enrollment 80 participants
Start Date 2024-09-15
Primary Completion 2025-03-21 (estimated)
Study Completion 2025-03-21 (estimated)
Updated on ClinicalTrials.gov 2025-02-25